NCT06764771 2025-12-17
A Study of BMS-986488 as Monotherapy and Combination Therapy in Participants With Advanced Malignant Tumors
Bristol-Myers Squibb
Phase 1 Active not recruiting
Bristol-Myers Squibb
Mirati Therapeutics Inc.
Mirati Therapeutics Inc.